# A Study to Evaluate VH4524184 Tablet Absorption, Effects of Food, and Interactions With Other Drugs in Healthy Adults

> **NCT07066722** · PHASE1 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 126 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** VH4524184
- **DRUG:** Itraconazole
- **DRUG:** Rifabutin
- **DRUG:** Phenytoin
- **DRUG:** Metformin
- **DRUG:** Digoxin

## Key facts

- **NCT ID:** NCT07066722
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-07
- **Primary completion:** 2025-12-17
- **Final completion:** 2025-12-17
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07066722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07066722, "A Study to Evaluate VH4524184 Tablet Absorption, Effects of Food, and Interactions With Other Drugs in Healthy Adults". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT07066722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*